Loading…
Predictors and Outcomes of Vitrectomy and Silicone Oil Injection in Advanced Diabetic Retinopathy
To evaluate visual and anatomical results and identify factors that influence vitrectomy and silicone oil (SO) injection outcomes in proliferative diabetic retinopathy (PDR). This retrospective study included 236 eyes with PDR that were undergoing vitrectomy and SO injection with >3-month follow-...
Saved in:
Published in: | Korean journal of ophthalmology 2017, 31(3), , pp.217-229 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c2668-3b30cd67ac20e402f0d5005278cb0f11c06a9b2cab888c7d0f6a60fdbfdf2ec93 |
---|---|
cites | cdi_FETCH-LOGICAL-c2668-3b30cd67ac20e402f0d5005278cb0f11c06a9b2cab888c7d0f6a60fdbfdf2ec93 |
container_end_page | 229 |
container_issue | 3 |
container_start_page | 217 |
container_title | Korean journal of ophthalmology |
container_volume | 31 |
creator | Ramezani, Alireza Ahmadieh, Hamid Rozegar, Amin Soheilian, Masoud Entezari, Morteza Moradian, Siamak Dehghan, Mohammad H Nikkhah, Homayoun Yaseri, Mehdi |
description | To evaluate visual and anatomical results and identify factors that influence vitrectomy and silicone oil (SO) injection outcomes in proliferative diabetic retinopathy (PDR).
This retrospective study included 236 eyes with PDR that were undergoing vitrectomy and SO injection with >3-month follow-up. The primary outcomes were final best-corrected visual acuity (BCVA) and retinal attachment rate.
At the final visit (mean, 88 ± 58 weeks), complete, partial, and no retinal attachment were observed in 86.9%, 10.6%, and 2.5% of patients, respectively. A total of 155 eyes had experienced SO removal, while 81 had SO in place. The mean initial BCVA was 1.9 ± 0.7 logarithm of the minimum angle of resolution (logMAR) and significantly improved to 1.7 ± 0.8 logMAR (p = 0.001). Initial macular detachment (adjusted odds ratio [AOR], 0.25), development of iatrogenic break (AOR, 0.25), and use of heavy SO (AOR, 0.13) were independently associated with a lower risk of final retinal attachment, and SO removal was associated with a higher incidence (AOR, 7.55). Better baseline BCVA was associated with a higher risk of final BCVA ≥20 / 200.
Despite an encouraging outcome based on anatomical data in advanced PDR treated with vitrectomy and SO, the functional prognosis was not satisfying for patients. Eyes with better vision at baseline had a more favorable prognosis, whereas eyes with initial macular detachment, intraoperative iatrogenic break, or heavy SO showed more unfavorable outcomes. In selected cases, extending the time of SO use did not worsen the prognosis. |
doi_str_mv | 10.3341/kjo.2016.0018 |
format | article |
fullrecord | <record><control><sourceid>proquest_nrf_k</sourceid><recordid>TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_1379563</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1901766743</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2668-3b30cd67ac20e402f0d5005278cb0f11c06a9b2cab888c7d0f6a60fdbfdf2ec93</originalsourceid><addsrcrecordid>eNpVkUtrGzEURkVpady0y26Llu1inCtpRqPZFEz6MgQckrRbodGjkT0judI44H9f2U5DikB38R19V3AQek9gzlhNLjbrOKdA-ByAiBdoRqGjVccEfYlmBAipRFfTM_Qm5zUAJwza1-iMiobV5cyQuk7WeD3FlLEKBq92k46jzTg6_MtPyZZo3B-jWz94HYPFKz_gZViXyMeAfcAL86CCtgZ_8aq3k9f4ptwhbtV0v3-LXjk1ZPvucZ6jn9--3l3-qK5W35eXi6tKU85FxXoG2vBWaQq2BurANAANbYXuwRGigauup1r1QgjdGnBccXCmd8ZRqzt2jj6dekNycqO9jMof5-8oN0kubu6WkrC2azgr7OcTu931ozXahimpQW6TH1XaH1_-nwR_X3oeZFPzrqNNKfj4WJDin53Nkxx91nYYVLBxlyXpgLSct_VhV3VCdYo5J-ue1hCQB4WyKJQHhfKgsPAfnv_tif7njP0FY6aZAQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1901766743</pqid></control><display><type>article</type><title>Predictors and Outcomes of Vitrectomy and Silicone Oil Injection in Advanced Diabetic Retinopathy</title><source>PubMed Central (Open Access)</source><creator>Ramezani, Alireza ; Ahmadieh, Hamid ; Rozegar, Amin ; Soheilian, Masoud ; Entezari, Morteza ; Moradian, Siamak ; Dehghan, Mohammad H ; Nikkhah, Homayoun ; Yaseri, Mehdi</creator><creatorcontrib>Ramezani, Alireza ; Ahmadieh, Hamid ; Rozegar, Amin ; Soheilian, Masoud ; Entezari, Morteza ; Moradian, Siamak ; Dehghan, Mohammad H ; Nikkhah, Homayoun ; Yaseri, Mehdi</creatorcontrib><description>To evaluate visual and anatomical results and identify factors that influence vitrectomy and silicone oil (SO) injection outcomes in proliferative diabetic retinopathy (PDR).
This retrospective study included 236 eyes with PDR that were undergoing vitrectomy and SO injection with >3-month follow-up. The primary outcomes were final best-corrected visual acuity (BCVA) and retinal attachment rate.
At the final visit (mean, 88 ± 58 weeks), complete, partial, and no retinal attachment were observed in 86.9%, 10.6%, and 2.5% of patients, respectively. A total of 155 eyes had experienced SO removal, while 81 had SO in place. The mean initial BCVA was 1.9 ± 0.7 logarithm of the minimum angle of resolution (logMAR) and significantly improved to 1.7 ± 0.8 logMAR (p = 0.001). Initial macular detachment (adjusted odds ratio [AOR], 0.25), development of iatrogenic break (AOR, 0.25), and use of heavy SO (AOR, 0.13) were independently associated with a lower risk of final retinal attachment, and SO removal was associated with a higher incidence (AOR, 7.55). Better baseline BCVA was associated with a higher risk of final BCVA ≥20 / 200.
Despite an encouraging outcome based on anatomical data in advanced PDR treated with vitrectomy and SO, the functional prognosis was not satisfying for patients. Eyes with better vision at baseline had a more favorable prognosis, whereas eyes with initial macular detachment, intraoperative iatrogenic break, or heavy SO showed more unfavorable outcomes. In selected cases, extending the time of SO use did not worsen the prognosis.</description><identifier>ISSN: 1011-8942</identifier><identifier>EISSN: 2092-9382</identifier><identifier>DOI: 10.3341/kjo.2016.0018</identifier><identifier>PMID: 28534343</identifier><language>eng</language><publisher>Korea (South): The Korean Ophthalmological Society</publisher><subject>Adult ; Aged ; Diabetic Retinopathy - diagnosis ; Diabetic Retinopathy - surgery ; Endotamponade - methods ; Female ; Follow-Up Studies ; Humans ; Injections ; Male ; Middle Aged ; Original ; Postoperative Complications ; Retrospective Studies ; Silicone Oils - administration & dosage ; Time Factors ; Treatment Outcome ; Visual Acuity ; Vitrectomy - methods ; Young Adult ; 안과학</subject><ispartof>Korean Journal of Ophthalmology, 2017, 31(3), , pp.217-229</ispartof><rights>2017 The Korean Ophthalmological Society</rights><rights>2017 The Korean Ophthalmological Society 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2668-3b30cd67ac20e402f0d5005278cb0f11c06a9b2cab888c7d0f6a60fdbfdf2ec93</citedby><cites>FETCH-LOGICAL-c2668-3b30cd67ac20e402f0d5005278cb0f11c06a9b2cab888c7d0f6a60fdbfdf2ec93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469925/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469925/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28534343$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002227613$$DAccess content in National Research Foundation of Korea (NRF)$$Hfree_for_read</backlink></links><search><creatorcontrib>Ramezani, Alireza</creatorcontrib><creatorcontrib>Ahmadieh, Hamid</creatorcontrib><creatorcontrib>Rozegar, Amin</creatorcontrib><creatorcontrib>Soheilian, Masoud</creatorcontrib><creatorcontrib>Entezari, Morteza</creatorcontrib><creatorcontrib>Moradian, Siamak</creatorcontrib><creatorcontrib>Dehghan, Mohammad H</creatorcontrib><creatorcontrib>Nikkhah, Homayoun</creatorcontrib><creatorcontrib>Yaseri, Mehdi</creatorcontrib><title>Predictors and Outcomes of Vitrectomy and Silicone Oil Injection in Advanced Diabetic Retinopathy</title><title>Korean journal of ophthalmology</title><addtitle>Korean J Ophthalmol</addtitle><description>To evaluate visual and anatomical results and identify factors that influence vitrectomy and silicone oil (SO) injection outcomes in proliferative diabetic retinopathy (PDR).
This retrospective study included 236 eyes with PDR that were undergoing vitrectomy and SO injection with >3-month follow-up. The primary outcomes were final best-corrected visual acuity (BCVA) and retinal attachment rate.
At the final visit (mean, 88 ± 58 weeks), complete, partial, and no retinal attachment were observed in 86.9%, 10.6%, and 2.5% of patients, respectively. A total of 155 eyes had experienced SO removal, while 81 had SO in place. The mean initial BCVA was 1.9 ± 0.7 logarithm of the minimum angle of resolution (logMAR) and significantly improved to 1.7 ± 0.8 logMAR (p = 0.001). Initial macular detachment (adjusted odds ratio [AOR], 0.25), development of iatrogenic break (AOR, 0.25), and use of heavy SO (AOR, 0.13) were independently associated with a lower risk of final retinal attachment, and SO removal was associated with a higher incidence (AOR, 7.55). Better baseline BCVA was associated with a higher risk of final BCVA ≥20 / 200.
Despite an encouraging outcome based on anatomical data in advanced PDR treated with vitrectomy and SO, the functional prognosis was not satisfying for patients. Eyes with better vision at baseline had a more favorable prognosis, whereas eyes with initial macular detachment, intraoperative iatrogenic break, or heavy SO showed more unfavorable outcomes. In selected cases, extending the time of SO use did not worsen the prognosis.</description><subject>Adult</subject><subject>Aged</subject><subject>Diabetic Retinopathy - diagnosis</subject><subject>Diabetic Retinopathy - surgery</subject><subject>Endotamponade - methods</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Injections</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Original</subject><subject>Postoperative Complications</subject><subject>Retrospective Studies</subject><subject>Silicone Oils - administration & dosage</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Visual Acuity</subject><subject>Vitrectomy - methods</subject><subject>Young Adult</subject><subject>안과학</subject><issn>1011-8942</issn><issn>2092-9382</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpVkUtrGzEURkVpady0y26Llu1inCtpRqPZFEz6MgQckrRbodGjkT0judI44H9f2U5DikB38R19V3AQek9gzlhNLjbrOKdA-ByAiBdoRqGjVccEfYlmBAipRFfTM_Qm5zUAJwza1-iMiobV5cyQuk7WeD3FlLEKBq92k46jzTg6_MtPyZZo3B-jWz94HYPFKz_gZViXyMeAfcAL86CCtgZ_8aq3k9f4ptwhbtV0v3-LXjk1ZPvucZ6jn9--3l3-qK5W35eXi6tKU85FxXoG2vBWaQq2BurANAANbYXuwRGigauup1r1QgjdGnBccXCmd8ZRqzt2jj6dekNycqO9jMof5-8oN0kubu6WkrC2azgr7OcTu931ozXahimpQW6TH1XaH1_-nwR_X3oeZFPzrqNNKfj4WJDin53Nkxx91nYYVLBxlyXpgLSct_VhV3VCdYo5J-ue1hCQB4WyKJQHhfKgsPAfnv_tif7njP0FY6aZAQ</recordid><startdate>201706</startdate><enddate>201706</enddate><creator>Ramezani, Alireza</creator><creator>Ahmadieh, Hamid</creator><creator>Rozegar, Amin</creator><creator>Soheilian, Masoud</creator><creator>Entezari, Morteza</creator><creator>Moradian, Siamak</creator><creator>Dehghan, Mohammad H</creator><creator>Nikkhah, Homayoun</creator><creator>Yaseri, Mehdi</creator><general>The Korean Ophthalmological Society</general><general>대한안과학회</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ACYCR</scope></search><sort><creationdate>201706</creationdate><title>Predictors and Outcomes of Vitrectomy and Silicone Oil Injection in Advanced Diabetic Retinopathy</title><author>Ramezani, Alireza ; Ahmadieh, Hamid ; Rozegar, Amin ; Soheilian, Masoud ; Entezari, Morteza ; Moradian, Siamak ; Dehghan, Mohammad H ; Nikkhah, Homayoun ; Yaseri, Mehdi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2668-3b30cd67ac20e402f0d5005278cb0f11c06a9b2cab888c7d0f6a60fdbfdf2ec93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Diabetic Retinopathy - diagnosis</topic><topic>Diabetic Retinopathy - surgery</topic><topic>Endotamponade - methods</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Injections</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Original</topic><topic>Postoperative Complications</topic><topic>Retrospective Studies</topic><topic>Silicone Oils - administration & dosage</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Visual Acuity</topic><topic>Vitrectomy - methods</topic><topic>Young Adult</topic><topic>안과학</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ramezani, Alireza</creatorcontrib><creatorcontrib>Ahmadieh, Hamid</creatorcontrib><creatorcontrib>Rozegar, Amin</creatorcontrib><creatorcontrib>Soheilian, Masoud</creatorcontrib><creatorcontrib>Entezari, Morteza</creatorcontrib><creatorcontrib>Moradian, Siamak</creatorcontrib><creatorcontrib>Dehghan, Mohammad H</creatorcontrib><creatorcontrib>Nikkhah, Homayoun</creatorcontrib><creatorcontrib>Yaseri, Mehdi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Korean Citation Index</collection><jtitle>Korean journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ramezani, Alireza</au><au>Ahmadieh, Hamid</au><au>Rozegar, Amin</au><au>Soheilian, Masoud</au><au>Entezari, Morteza</au><au>Moradian, Siamak</au><au>Dehghan, Mohammad H</au><au>Nikkhah, Homayoun</au><au>Yaseri, Mehdi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predictors and Outcomes of Vitrectomy and Silicone Oil Injection in Advanced Diabetic Retinopathy</atitle><jtitle>Korean journal of ophthalmology</jtitle><addtitle>Korean J Ophthalmol</addtitle><date>2017-06</date><risdate>2017</risdate><volume>31</volume><issue>3</issue><spage>217</spage><epage>229</epage><pages>217-229</pages><issn>1011-8942</issn><eissn>2092-9382</eissn><abstract>To evaluate visual and anatomical results and identify factors that influence vitrectomy and silicone oil (SO) injection outcomes in proliferative diabetic retinopathy (PDR).
This retrospective study included 236 eyes with PDR that were undergoing vitrectomy and SO injection with >3-month follow-up. The primary outcomes were final best-corrected visual acuity (BCVA) and retinal attachment rate.
At the final visit (mean, 88 ± 58 weeks), complete, partial, and no retinal attachment were observed in 86.9%, 10.6%, and 2.5% of patients, respectively. A total of 155 eyes had experienced SO removal, while 81 had SO in place. The mean initial BCVA was 1.9 ± 0.7 logarithm of the minimum angle of resolution (logMAR) and significantly improved to 1.7 ± 0.8 logMAR (p = 0.001). Initial macular detachment (adjusted odds ratio [AOR], 0.25), development of iatrogenic break (AOR, 0.25), and use of heavy SO (AOR, 0.13) were independently associated with a lower risk of final retinal attachment, and SO removal was associated with a higher incidence (AOR, 7.55). Better baseline BCVA was associated with a higher risk of final BCVA ≥20 / 200.
Despite an encouraging outcome based on anatomical data in advanced PDR treated with vitrectomy and SO, the functional prognosis was not satisfying for patients. Eyes with better vision at baseline had a more favorable prognosis, whereas eyes with initial macular detachment, intraoperative iatrogenic break, or heavy SO showed more unfavorable outcomes. In selected cases, extending the time of SO use did not worsen the prognosis.</abstract><cop>Korea (South)</cop><pub>The Korean Ophthalmological Society</pub><pmid>28534343</pmid><doi>10.3341/kjo.2016.0018</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1011-8942 |
ispartof | Korean Journal of Ophthalmology, 2017, 31(3), , pp.217-229 |
issn | 1011-8942 2092-9382 |
language | eng |
recordid | cdi_nrf_kci_oai_kci_go_kr_ARTI_1379563 |
source | PubMed Central (Open Access) |
subjects | Adult Aged Diabetic Retinopathy - diagnosis Diabetic Retinopathy - surgery Endotamponade - methods Female Follow-Up Studies Humans Injections Male Middle Aged Original Postoperative Complications Retrospective Studies Silicone Oils - administration & dosage Time Factors Treatment Outcome Visual Acuity Vitrectomy - methods Young Adult 안과학 |
title | Predictors and Outcomes of Vitrectomy and Silicone Oil Injection in Advanced Diabetic Retinopathy |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T15%3A39%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_nrf_k&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predictors%20and%20Outcomes%20of%20Vitrectomy%20and%20Silicone%20Oil%20Injection%20in%20Advanced%20Diabetic%20Retinopathy&rft.jtitle=Korean%20journal%20of%20ophthalmology&rft.au=Ramezani,%20Alireza&rft.date=2017-06&rft.volume=31&rft.issue=3&rft.spage=217&rft.epage=229&rft.pages=217-229&rft.issn=1011-8942&rft.eissn=2092-9382&rft_id=info:doi/10.3341/kjo.2016.0018&rft_dat=%3Cproquest_nrf_k%3E1901766743%3C/proquest_nrf_k%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2668-3b30cd67ac20e402f0d5005278cb0f11c06a9b2cab888c7d0f6a60fdbfdf2ec93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1901766743&rft_id=info:pmid/28534343&rfr_iscdi=true |